Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial

Discussion: Rasagiline did not alter disease progression compared with controls over 12 months of treatment.Muscle Nerve, 2017

Source: Muscle and Nerve - November 26, 2018 Category: Internal Medicine Authors: Jeffrey M. Statland, Dan Moore, Yunxia Wang, Maureen Walsh, Tahseen Mozaffar, Lauren Elman, Sharon P. Nations, Hiroshi Mitsumoto, J. Americo Fernandes, David Saperstein, Ghazala Hayat, Laura Herbelin, Chafic Karam, Jonathan Katz, Heather M. Tags: Clinical Research Source Type: research